Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company” or 'Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a ...

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe, and ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...

Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Fortress Biotech (FBIO) could be a great choice. It is one of the several stocks ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...